HC sets aside Centre's ban on pvt firms making, selling oxytocin
- Country:
- India
The Delhi High Court on Friday set aside the Centre's decision to ban private firms from making and selling oxytocin, a drug which induces labour and controls bleeding during child birth.
A bench of Justices S Ravindra Bhat and A K Chawla quashed the government's April 27 notification imposing the ban, saying it was "arbitrary and unreasonable".
The court also said the Centre's decision to allow only a single state-run entity with no prior experience in manufacturing oxytocin to make and sell the drug, which has wide public use, was "fraught with potential adverse consequences".
The order came on the pleas of BGP Products Operations GmbH, a subsidiary of Mylan Laboratories, Neon Laboratories and NGO All India Drug Action Network (AIDAN), which works to ensure access to essential medicines.
Oxytocin is also administered to pregnant women to "prevent and treat" postpartum haemorrhage (PPH). PPH accounts for about 35 per cent of all maternal deaths, as per the World Health Organisation (WHO).
As per the notification, the state-run Karnataka Antibiotics and Pharmaceuticals Ltd (KAPL) was solely allowed by the Centre to make the drug to meet the country's needs.
The high court had on August 31, suspended till September 30, the central government's prohibition on sale and manufacture of oxytocin by private companies for domestic use.
The stay was later extended till December 15.
Thereafter, the court had extended the stay from time to time while it was hearing arguments in the matter.
The court had earlier noted that the material placed before it showed that when the decision was taken in February this year to restrict the sale of Oxytocin, KAPL was not even licensed to manufacture the drug and it was issued the licence only in April this year.
Some private companies which made and sold the drug in India are Pfizer, Mylan and Neon.
The NGO, meanwhile, had contended in its plea that it would not be advisable to depend on one company alone, especially when it allegedly has not made the product earlier.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Year
- Light-year
- 7 Years
- European Union (Notification of Withdrawal) Act 2017
- Time
- The Times
- Universal Time
- Court
- Delhi High Court
- District Court
- Centre's ban
- private companies
- manufacture of oxytocin
- private firms
- Neon Laboratories
- manufacturing oxytocin
- KAPL
- notification
- NGO
- National News
ALSO READ
Planters' body in NE opposes govt notification to sell 100 pc tea through auction
HC dismisses petition against EC notification for Karnal Assembly bypoll
Jharkhand: HC refuses to interfere with earlier order over notification of civic polls
Admission Notification for IIFT's 5 Year Integrated Program in Management (BBA in Business Analytics and MBA in International Business) 2024–29 Programme at Kakinada Campus
Andhra Pradesh CEO directs officials to be ready for polls as notification will be issued on Apr 18